QLGN Nilai Total Aset Perusahaan Qualigen Therapeutics Inc

QLGN (Qualigen) - tandha merek perusahaan

The market trend for the total assets of Qualigen Therapeutics (QLGN), which reached 25.63, demonstrates a business foundation based on the implementation of FastPack systems and oncology research. The company is currently actively developing its R&D sector, creating targeted molecules against cancer and viruses. However, the strategic shift toward pharmaceuticals entails serious financial risks and a dependency on the success of new clinical trials.

QLGN (Qualigen Therapeutics) riwayat Total Aset Perusahaan saka 04.07.2022 nganti 19.11.2025

Rincian analitis lan laporan data perusahaan Qualigen (QLGN)

- kuotasi lan prakiraan analis:
Kurs saham qualigeninc.com|QLGN - Bagan rega target
- data kapitalisasi pasar:
Biji pasar Qualigen Corp|QLGN - Nilai Perusahaan
- statistik nilai buku emiten:
Nilai Akuntansi Saham Qualigen Therapeutics|QLGN - Kapitalisasi Buku|Rasio Kapitalisasi Pasar marang Nilai Buku qualigeninc.com|QLGN - Aset Agregat Perusahaan
- indikator beban utang lan likuiditas:
Rasio Kabeh Utang marang Dana Pribadi Qualigen Therapeutics|QLGN - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas Qualigen Corp|QLGN - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Qualigen Corp|QLGN - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Qualigen Therapeutics|Likuiditas cepet qualigeninc.com
- indikator pendapatan resik lan kelipatan nilai:
QLGN - Bathi resik
Pambiji fundamental:Qualigen Therapeutics
Produk sing diprodhuksi Qualigen Therapeutics

Scaling diagnostic systems and developing oncology drugs at Qualigen Therapeutics (QLGN) requires significant resources, the volume of which is reverse-calculated via return on assets (ROA) to strip the balance sheet mass of one-off market distortions. This method measures total capital and liabilities, where stable dynamics confirm financial resilience, while sharp deviations in the structure of assets and resources signal critical risks.

Pesaing wigati

Total Aset Bisnis GILD|Aset Agregat Perusahaan cidara.com|Novavax Inc - Nilai Total Aset Perusahaan|Total Aset Perusahaan CVAC|VALN (Valneva Vaccines) - Nilai Agregat Aset|Total Aset Perusahaan VIR (Vir Biotechnology, Inc.)|Total Aset Perusahaan siga.com SIGA|EBS - Aset Agregat Perusahaan|Nilai Agregat Aset AVIR (Atea Pharma)|invivyd.com (IVVD) - Aset Agregat Perusahaan|Gunggung Aset Perusahaan Enanta Pharmaceuticals, Inc|INO (Inovio Pharmaceuticals) - Total Aset Perusahaan|Total Aset Perusahaan hillevax.com|Gunggung Aset Perusahaan KLRS (Kalaris Therapeutics)|DYAI (dyadic.com) - Nilai Agregat Aset|NanoViricides - Gunggung Aset Perusahaan|Talphera Corporation - Aset Agregat Perusahaan|Cocrystal Pharma, Inc. - Total Aset Perusahaan|Gunggung Aset Perusahaan Traws Pharma, Inc. TRAW|dwtx.com (DWTX) - Aset Agregat Perusahaan|AlloVir - Nilai Agregat Aset|Gunggung Aset Perusahaan VBIV|Total Aset Perusahaan Virios|Aset Agregat Perusahaan Vaxart, Inc. (VXRT)